Sunopta Inc
F:ZSK
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.51
7.64
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Greetings, and welcome to SunOpta's Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the prepared remarks. As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Reed Anderson with ICR. Thank you. You may begin.
Good afternoon, and thank you for joining us on SunOpta's Second Quarter Fiscal 2023 Earnings Conference Call. On the call today are Joe Ennen, Chief Executive Officer; and Scott Huckins, Chief Financial Officer. By now, everyone should have access to the earnings press release that was issued earlier this afternoon and is available on the Investor Relations page of SunOpta's website at www.sunopta.com. This call is being webcast, and this transcription will also be available on the company's website. As a reminder, please note that the prepared remarks which will follow contain forward-looking statements, and management may make additional forward-looking statements in response to your questions. These statements do not guarantee future performance, and therefore, undue reliance should not be placed upon them. We refer you to all risk factors contained in SunOpta's press release issued this afternoon, the company's annual report filed on Form 10-K and other filings with the Securities and Exchange Commission for a more detailed discussion of the factors that could cause actual results to differ materially from those projections in any forward-looking statements. The company undertakes no obligation to publicly correct or update the forward-looking statements made during the presentation to reflect future events or circumstances as may be required under applicable securities laws. Finally, we would like to remind listeners that the company may refer to certain non-GAAP financial measures during this teleconference. A reconciliation of these non-GAAP financial measures was included with the company's press release issued earlier today. Also, please note that unless otherwise stated, all figures discussed today are in U.S. dollars and occasionally rounded to the nearest million. Please note, in the prepared remarks to follow, the company will generally exclude the impact of the divested [Indiscernible] for our business. I'd now like to turn the call over to Joe.
Good afternoon, and thank you for joining us today. We signaled last quarter that Q2 was going to be soft. It proved to be more challenging than we anticipated. The nature of the headwinds are short term in nature and do not reflect SunOpta's long-term potential. Several of the issues we encountered in Q2 were related to broader factors affecting our industry and similar companies. The 3 specific issues are category softness in tracked channels, broth and frozen fruit, and third, timing of new business. To be specific, we had 10 new business opportunities that informed our guidance. 6 of them are contracted and happening, but are slower to commercialize slash ramp-up than we planned, 2 are on pace and 2 of them didn't materialize. Let me offer some key takeaways before we begin unpacking the quarterly results. I'll group them into onetime events, concerns and bright spots. There are 2 significant onetime events that impacted the quarter, the first being the frozen fruit recall. This was a significant distraction for the team in Q2. And while the financial impact wasn't huge with insurance covering a significant majority of the cost, it undoubtedly consumed a sizable portion of leadership's time within the quarter. The second is the previously communicated $7 million of onetime plant-based revenue from Q2 of 2022 that we overlapped. Importantly, adjusting for this overlap, our core packaged plant-based milk growth was 10% in Q2. In terms of concerns, several of our co-manufacturing customers experienced soft volume in the quarter, resulting from tracked channel headwinds. This not only impacted big existing customers but also impacted the plans of 2 of our entrepreneurial growth-oriented new customers we were planning to onboard in the second half of 2023. In terms of bright spots in the quarter we continue to see strength from our core growth levers, strong growth with several of our largest customers, fruit snacks, oat milk and Texas. We remain very confident in our ability to deliver our long-term guidance. At several investor events, I've outlined our 5 strategic imperatives. A brief update against these will help you understand our continued optimism. Our first imperative is fortifying our competitive advantages. Within plant-based, we continue to win a larger share of customers' business because of our customer value proposition, our ability to execute and our capacity additions, all of which gives our customers runway for growth and redundancy of supply. Capacity adds in oat milk, fruit snacks, tea and Texas in general, have all attracted share expansion and new customers. I will share some specifics to underline this point. We are growing share at our largest customer in both tea and oat milk with Dream Oat milk sales up 89%. By the end of the year, we will be the exclusive supplier for both of our major tea customers for the first time ever. We also signed a contract extension with our largest national brand customer through 2028 and beginning in 2024, we will be their exclusive U.S. supplier. These share gains along with other new business wins demonstrates our real competitive advantages. Our second imperative is expanding the TAM of the business. Our biggest TAM expansion is our entry into the $5 billion nutrition beverage category. And this new business will deliver growth in the second half of 2023 in 2024, and it represents a major long-term white space for us. We are still in the ramp-up phase of producing this product. We are meeting our customers' expectations for volume production, and we expect to continue to accelerate towards our long-term run rate by the end of the year. Third is portfolio transformation. Over the last several years, we have made material progress transforming the portfolio from commodity oriented to a focus on value-added manufacturing. We have flipped the portfolio from 70-30 commodity value added to 30/70, and we are absolutely focused on continued transformation. Fourth is sustainability. We are making real progress as evidenced by upgrades from 2 of the most respected rating agencies. We believe strong sustainability reporting around Scope 1 and 2 will be a competitive advantage as it becomes a must-have for our customers. Lastly, our culture is a significant point of difference for us. We have built a team that has a real passion to win, is focused on customers and execution. These are the things that will propel us forward. I mentioned the category softness. In plant-based, we are seeing more bifurcation between retail and foodservice. We do not believe nor have we seen a structural change in consumers' attitudes towards plant-based milks. The category has over 50% household penetration and a 10-year CAGR of 10%. There are enduring demand drivers such as lactose intolerance, taste preferences for plant-based milks over milk from a cow and health benefits, both for the individual and the planet. I believe the retail category headwinds are a short-term function of the inflationary environment and its impact on real wages. We know plant-based milks are more expensive. For example, in a leading retailer plant-based milk is $0.05 an ounce compared to dairy milk at $0.02 an ounce. As inflation softens, we would expect to return to growth, and this view is supported by research, which project a double-digit CAGR for the category over the next decade as millennials and Gen Z fully take center stage as the drivers of the U.S. economy. While the quarter was disappointing, our business development pipeline contains several significant new opportunities. This, along with significant share gains in existing customers that I outlined previously, along with TAM expansion, gives us confidence in our long-term growth plans. Our snacks capacity expansion is on track for the end of Q3, and we are excited that we will be able to continue to drive growth in this business. In closing, as a major shareholder myself, I share your frustration with the current stock price performance. TTM EBITDA is more than 50% higher than what it was the last time the stock traded at these levels. Our major capital projects are complete, cash flow is positive, we are a much stronger company than our share price suggests. I will end by saying that we have grown the plant-based business 87% in the last 48 months, and we have more than doubled our fruit snacks business in that same time frame. We are in the right categories with the right value proposition, we have demonstrated executional capabilities, we've built great manufacturing assets and our team's passion to win is stronger than ever. We are excited about the future of SunOpta and look forward to improved results in future quarters. Now I'll turn the call over to Scott to take us through an update on the key commercial activities and the rest of the financials. Scott?
Thank you very much, Joe, and good afternoon, everyone. Let me start by reviewing the key commercial activities in each segment in the second quarter. Plant-based segment revenues were down 8% year-over-year to $114 million. Relative to our expectations, revenue was off approximately $15 million and was driven by 2 factors: one, the timing of new business; and two, category influenced national brand performance. The timing of new business was affected by a number of frustratingly unrelated factors, including slow customer setup, slow transition from existing suppliers to SunOpta and significant, albeit temporary supply chain-related disruptions at one of our key customers. Tracked channel data for plant-based milks in Q2 showed softness throughout the quarter with sales up 1% and volume down 8% and performance in shelf-stable was slightly worse. Track channel data reports oat milk sales grew 9% on flat volume, with almond milk sales down 3% on 10% lower volumes. SunOpta total plant-based milk results across all channels were up 1% on 9% lower volumes. Oat milk sales grew 59%, including a 58% increase in volume, and our creamer sales were up 27% on double-digit volume growth. Largely offsetting the growth in oat was almond milk, which included the onetime revenue overlap we called out in Q2 of last year. As Joe mentioned, removing this overlap, packaged plant-based milk sales grew 10%. Looking at our business by customer, as you'd expect, results were mixed in Q2. 3 of our top 5 customers delivered growth, including 2 with double-digit gains aided by the strength of our oat-based offerings. As mentioned, we have increased share with 3 of our top 5 customers, most of which will begin later in 2023 and into 2024. Looking at results on a go-to-market basis, owned brands remain the top performing area with sales up 27% versus last year, driven by equally strong growth in both Dream and soy. Private label also had a solid quarter of high single-digit growth reflecting gains in nondairy with major retail customers. The decline in our co-man business more than offset growth in owned brands in private label, reflecting softness in the category and the timing overlap in almond milk. Similar to Q1, our ingredients business was down for the reasons that we outlined on the Q1 call. Importantly, we have completed the restaging of oat-based to finished goods at the end of Q2. We continue to ramp production at our Texas facility, including our new 330 milliliter protein shake line. This facility gives us sufficient capacity to reach our goal of doubling the plant-based business off of the 2020 base, along with enhanced capabilities and providing a strategically advantaged location for many of our current and new customers. Moving to our Fruit-Based segment. Snacks continued to be the key story. Fruit snack sales were up nearly 14% driven primarily by volume growth, reflecting strong underlying trends in consumption as well as the strength of our platform to support innovation and provide incremental capacity to our customers. More than offsetting the growth in fruit snacks was softness in our frozen business, which was down 10% due to supply constraints, together with unfavorable consumption trends that negatively impacted retail volumes and foodservice orders, along with the recall in June. Overall, our Fruit-based segment revenues were down 4% in the second quarter versus last year, mostly driven by frozen volume. We could continue to have a significant pipeline of potential growth opportunities in our snack business and look forward to the additional capacity coming online here in the third quarter, which will provide headroom to grow this business by another 40% over time. Now let me walk through the more detailed financial results in the quarter. Second quarter revenues of $208 million were down 6% versus last year, adjusted for the divestiture of the sunflower business. Adjusted gross profit, removing start-up and recall costs was $25.3 million or 12.1% of revenue, down $7 million versus last year on a like-for-like basis, reflecting lower volumes. In plant-based, segment level gross margin was 12.6% as reported and adjusted for start-up costs in Texas was 17.5%, a 90 basis point improvement over the prior year period. In fruit-based segment level gross margin as reported was 2.1% and adjusted for the frozen fruit recall, was 5.5%, a 570 basis point decline versus last year. The margin decline was driven almost entirely by our frozen fruit business, principally impacted by an unfavorable sales mix and a stronger Mexican peso. You can see on the face of the P&L, a $2.4 million FX gain, while the effect of the higher cost inventory for Mexico reduces gross profit. I also want to provide a few comments on the voluntary frozen fruit recall we initiated in June. Specifically, we issued out of an abundance of caution, a voluntary recall of specific frozen fruit products linked to pineapple provided by a third-party supplier. As you would expect, we have permanently terminated our relationship with that supplier. From a financial perspective, we have insurance for this event in our Q2 results reflect a net $2.5 million expense, which is our deductible under these insurance programs. There was limited impact on revenue in Q2 and the affected customers have turned replenishment orders back on in Q3. Adjusted loss from continuing operations was $3 million compared to $3.3 million of income in the prior year period. Adjusted EBITDA, as reported, decreased 9.8% to $20.2 million and was up 50 basis points as a percent of consolidated revenue to 9.7%. As a reminder, last year's adjusted EBITDA included a $2.4 million contribution from the divested sunflower business. On an apples-to-apples basis, this quarter's EBITDA is flat to last year's. TTM EBITDA is $89.4 million, up $25 million or 39% versus the prior 12-month period. Turning to the balance sheet and cash flow. At the end of Q2, total debt was $336 million with leverage of 3.7x, in line with our target leverage of 2 to 4x. We continue to expect to be within that range at year-end 2023. Cash provided by operating activities during the second quarter of 2023 was a strong $16 million compared to cash used in operating activities of $2 million in the prior year. This improvement reflects the effective management of working capital and inventory in particular. Cash used in investing activities was $8 million compared to $34 million last year. The step down in capital expenditures was expected, reflecting the completion of our Midlothian, Texas plant. There are no huge projects on the near-term horizon and CapEx will continue to moderate. Let me close with comments on our outlook, recognizing the environment remains very fluid. From a guidance standpoint, we are revising our 2023 estimates that were first provided on our Q4 call. We now expect revenue in the range of $880 million to $900 million. For the second half of 2023, the revisions are attributable to; one, category softness in track channels; two, increased competition in frozen fruit and broth, and three, the timing of new business in plant-based. This outlook, excluding the divested sunflower business results in the plant-based segment growing in the high single digits in the second half of 2023 with core packaged plant-based milks growing low double digits, partially offset by headwinds in broth and ingredients. From a profit perspective, we expect adjusted EBITDA of $87 million to $91 million. From a pacing standpoint for the total company, we would expect Q4 to be stronger than Q3. Finally, we would expect approximately $2 million to $4 million in start-up costs in the second half, with the majority occurring in Q3. For conservativeness, we have assumed that the 3 headwinds remain in the second half of 2023. However, we have the opportunity to deliver better results from category improvement, along with the possibility for a steeper ramp up in production in Texas and in fruit snacks and for their productivity efforts. From a balance sheet and cash flow standpoint, we continue to expect capital expenditures on the cash flow statement of approximately $45 million. Consistent with this, we expect unlevered free cash flow in the $25 million to $35 million range. Before opening the call for questions, just a reminder that for competitive reasons, we do not provide detailed commentary regarding customer or SKU level activity. And with that, operator, please open up the call for questions.
[Operator instructions]. Your first question comes from [ Jim Salera ] with Stephens.
If you could maybe provide a little more color on the 10 business opportunities that you guys had planned on. The six a little bit slow and then the 2 that fell through. Just any detail on kind of what the moving pieces were there and if there's a chance maybe to accelerate the 6 that are slow and if the 2 that fell off are permanently fallen off, or if there's a chance to maybe pick those up down the road?
Yes. Thanks, Jim. As we outlined, 10 key projects, 2 of them that didn't happen were not the biggest opportunities, but we're really a function of they had lofty expectations based on category growth a year ago that didn't materialize in their plans to get on shelf were somewhat thwarted by retailers lack of enthusiasm for adding new brands into the category. As it relates to the 6, as I mentioned, all of them are contracted, all of them are now ramping up. They're just slower than we thought. I would give you -- if I could summarize kind of one core reason. It was -- many of those 6 were situations where we were taking business from one of our competitors. And with the category slowing down, those competitors had excess packaging, excess finished goods that the customer allowed them to work through thereby delaying their move from competitor XYZ to SunOpta. But we're kind of fully over the hump with most of those and I would say the average delay was circa 3, 4 months, something like that. Certainly, frustrating because we build guidance and our expectations based on the time lines that were committed by them. But at the end of the day, we're happy to have those new customers on board and producing and will certainly contribute to kind of back half business as well as growth in 2024.
Okay. Great. And then on the key volumes with the customer, just kind of lack of an ability to get raw material, is that something that we should keep our antenna up for as maybe there's some increased supply chain dislocations coming or is this kind of unique to one customer? Any color you could give us on that would be helpful as well.
Very unique to one customer. It is the customer where they provide us the ingredient, meaning they provide us the tea and they are having some transitional -- more IT transition timing, so that's not like there's a crop failure or anything like that. It's really linked to changes in their business structure, standing up a new IT system and their IT system basically functioning and providing us tea leaves that we then turn into finished goods. We would expect and I hope we just had a call with them this morning, we would expect and hope probably be some continued bumpiness in Q3 but they fully expect to have it behind them by Q4.
Got it. That's helpful. And then maybe if I could just sneak in one more. As you guys step up your move to being the exclusive supplier for a couple of your larger customers, does all of that incremental business with them just flow into the addition that you've made in Midlothian? Or do you have to pull some other stuff off on existing lines and [ swarm ] in those customers to meet that step-up in demand.
No. We won't have to pull anything off existing lines. It just slots into capacity additions we've made. Certainly, in a number of instances, Texas provided redundancy in capabilities like tea, where we used to only have 1 tea extraction system. We now have 2 giving the customer confidence to give 100% of their business to SunOpta because we have some redundancy and manufacturing that we never used to have. But no, we won't have to do any kind of restaging or business resignations. We're fully capable of supporting the incremental volume that's coming our way.
Your next question comes from Ryan Meyers with Lake Street Capital Markets.
First one for me. I'm just curious, as we think about the full year guidance, how much does that bake in improved industry demand trends? And then also, if you could kind of just speak a little bit more to what you're seeing in that category softness, I think would be helpful.
Yes. So we did not bake in improvements in category performance. As I articulated, we certainly believe the category long term has a lot of positives going for it. Just candidly, we don't have any information that would tell us to kind of September 1, it's going to turn around or October 1. So we're just operating off of the information we have today, which is why Scott called it out as a potential upside. The thing I will point out, and we've made this point several times, tracked channels is roughly 1/3 of our business. So we have growth in many of the other channels. Scott, I think, referenced category was down 8% in volume. So that we're not immune to softness in 1/3 of the category when it's down 8%. But foodservice was up for us again. It's been a strength of ours for many years. And we're also seeing solid growth in e-commerce and club. So we feel good about the diversified channel mix that we've built, and we're certainly performing better than the overall category and a track channel basis, but does definitely represent a headwind.
Got it. And then as we think about the more longer-term guide or so the targets that you guys have given in the past for FY '24, I think it was $1.1 billion in revenue and $120 million does the sort of 3 areas of softness that you're seeing right here, does that change anything for next year?
It does not. Our view -- it doesn't change our view for 2024. The vast majority of the growth levers that we built into that guidance are happening. And we're confident in the long-term strength of the category. So no, we're not revising 2024 or 2025, we still believe in those targets to.
Your next question comes from Andrew Strelzik with BMO.
I'd like to hear you talk maybe a little bit more about what you're seeing outside of the retail environment. The other 2/3 of your business, you've talked about strength, obviously. But are you seeing any softness there, any slowdown? Have you incorporated any cushion in your guidance on that side? Or are you seeing that really hold consistent?
So we're definitely continuing to see strength there. Where we have really good visibility into the numbers. We saw overall double-digit growth in the foodservice channel. There's also a component, and this is where our business gets a little bit tricky to understand sometimes, we make an estimate of the national brands that we produce for what portion of that volume flows into foodservice. And so there was a little bit of headwind there if our estimates are accurate, but the kind of where we sell direct into foodservice, we continue to see strength.
Okay. And maybe if you could just talk a little bit about what you saw through the quarter? And are you seeing that the retail side of the business start to stabilize at that lower level? Or are we kind of continuing to see the accelerating declines, I guess?
I think it's fairly stable at those levels, Andrew. It's not further decelerating if we look at, say, the 4-week data versus the 12 week.
Got it. And then I guess just as we think about bridging -- this will be my last one, I apologize. If we think about bridging from the sales guidance and the reduction there to the profit impact, I mean are there any cost opportunities or anything you guys are doing differently as you kind of take down to have reasonably more steady EBITDA relative to the reduction on the top line? Just anything that you've contemplated there, that would be great to hear.
Yes, Andrew, it's Scott. It's a good question. I'd say it's probably 2 core activities, some you can even see in the Q2 financial statements. I think I mentioned in my prepared remarks, we've done a very good job managing the inventory quantum, the environment that we're in. I mentioned it was a significant outperformance versus last year. But I think as you would expect, making sure that production volumes are bang on what demand is, then you're not over or under delivering your customer and you're not building or declining inventory. So I think we are managing the business, I think, actively on that basis on both fronts.
Your next question comes from Bobby Burleson with Canaccord.
So I was just curious on the customer programs that were slower to get going than expected. It sounds like the 2 that dropped off were in part due to that category softness. And I'm wondering how much you think the slower and expected ramp for those 6 customers or the 6 programs is also due to the category weakness.
I think it was absolutely a contributor Bobby, because the way this works is if they're moving from a competitor to us, they're trying to calculate, okay, when will they be out of inventory and out of packaging materials and out of ingredients with one of our competitors in order to then move business to us. Well, if the category slows down, the inventory builds up, the ingredients build up, packaging builds up. And there's a fairly common respected practice in the industry if you don't screw somebody when you're moving and you allow them to work through whatever finished goods and dedicated specific packaging they have. So we've just seen a slower pace. I mean, some of it is just a frustrating a bit of bureaucracy with some of the bigger packaged goods companies. But overall, again, as I mentioned, they're all contracted. They're all coming. They were just several months lower than we had planned and built into our guidance.
Okay. Great. And then just on the overall kind of inflationary environments impact on consumer purchasing and you guys pointed out the premium nature of the category. But it sounds like oat milk creamer did well. So do you think folks were driving -- were buying multiple types of plant-based milk and then they just cut out the almond milk or what kind of reconciles the strength in certain areas of the category and the overall kind of thesis that consumer wallets being pressured and is impacting category volumes.
Yes. I mean oat milk has done well as a product since introduction, call it, 5 years ago in earnest. And so we continue to see growth there, especially in foodservice. It is a product that pairs incredibly well with coffee. And so it's not surprising to us that we continue to see it do well in coffee applications, be it creamers, barista blends or in food service. So I don't think that dynamic is as much pricing. One of the things that you referenced in your question, we have seen, which is the average household that buys plant-based milks buys 2.3 different varieties, and we have seen a bit of skinning up, meaning instead of a household buying both almond milk and oat milk, which might be all in $8, $9, $10, they're buying just one product instead of 2, which doesn't necessarily change the amount that gets consumed in the household, but it changes the amount that goes through the basket on a short-term basis.
Your next question comes from Alex Fuhrman with Craig Hallum Capital Group.
It sounds like, Joe, from your -- from some of your comments earlier, it sounds like you're not really seeing much or any weakness in the food service channel. I'm curious, is it just that the food service channel was so strong for you that it continues to be up despite maybe seeing a little bit of a sequential slowdown? Or has it really just been a tale of 2 completely different trajectories in foodservice and in track channels?
Yes. As I mentioned, I mean, we're definitely seeing more bifurcation in performance between foodservice and retail. I think it's possible the consumer is just less price sensitive when they're in a coffee shop ordering their favorite drink versus in a grocery store where they have a basket of items, they need to purchase to feed themselves and their family. And so maybe there's just more price sensitivity in a retail environment than there is at the drive-thru for your morning oat milk latte. But that is definitely something we're seeing. And we haven't seen any signs of a slowdown, as I mentioned, where we do have good visibility into the data in foodservice, we're seeing low double-digit growth.
Okay. That's really helpful. And then I think you called out a couple of times in the release and on the conference call that oat continues to be a really strong performer. Are there any particular nuts or seeds or grains that have been slowing down? And then as you think about continuing to optimize your production in Midlothian, are there maybe any way that you might differently allocate production given what you've been seeing since the last update?
Yes, we're seeing a bit of an acceleration or deceleration, if you will, in almond milk at a category takeaway basis, which is a little bit surprising, but almond milk is the lion's share of the category still, I mean, it's 60%. So if something is going to be a shared donor, it's typically usually the biggest thing in the category. But that's the answer to your question. In terms of impact on Midlothian, our assets are pretty fungible in terms of ability to run almond milk versus oat milk, et cetera. So while we love running products where we're doing both the extraction and the processing side of it, we don't -- certainly, our assets are capable of making a quick pivot. And as I've mentioned in the past, things like oat milk where we're doing both extraction as well as the packaging side of it affords us better margins because we're making a margin on the extraction as well as the packaging.
There are no further questions at this time. With that, I will now turn the call back over to Joe Ennen for closing remarks.
I just want to say thank you. I appreciate your interest and time this evening and look forward to talking to all of you in the future. Thank you.
This will conclude today's conference call. Thank you for joining us. You may now disconnect.